The Effect of N^G -monomethyl-L-arginine and Tamoxifen on Nitric Oxide Production in Breast Cancer Cells Stimulated by Oestrogen and Progesterone

References

• Alalami O, Martin JH. ZR-75-1 human breast cancer cells: expression of inducible nitric oxide synthase and effect of tamoxifen and phorbol ester on nitric oxide production. Cancer Lett 1998; 123: 99–105.
   Google Scholar
• Armour KE, Ralston SH. Estrogen upregulates endothe-lial constitutive nitric oxide synthase expression in human osteoblast-like cells. Endocrinology 1998; 139: 799–802.
   PubMed Web of Science ®Google Scholar
• Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor oc mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999; 103: 401–406.
   Google Scholar
• Cowan LD, Gordis L, Tonascia JA, Jones GS. Breast cancer incidence in women with a history of progester-one deficiency. Am J Epidemiol 1981; 114: 209–217.
   PubMed Web of Science ®Google Scholar
• Dong YL, Fang L, Gangula PR, Yallampalli C. Regu-lation of inducible nitric oxide synthase messenger ribonucleic acid expression in pregnant rat uterus. Biol Reprod 1998; 59: 933–940.
   Google Scholar
• Duenas-Gonzalez A, Isales CM, del Mar Abad-Hernan-dez M, Gonzalez-Sarmiento R, Sangueza O, Rodriguez- Commes J. Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Mol Pathol 1997; 10: 645–649.
   Google Scholar
• Friedl A, Jordan VC. Oestradiol stimulates growth of oestrogen receptor-negative MDA-MB-231 breast can-cer cells in immunodeficient mice by reducing cell loss. Eur J Cancer 1994; 30A: 1559–1564.
   Google Scholar
• Garliardi AR, Hennig B, Collins DC. Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factor. Anticancer Res 1996; 16: 1101–1106.
   Google Scholar
• Guinee VF, Olsson H, Moller T, et al. Effect of preg-nancy on prognosis for young women with breast cancer. Lancet 1994; 343: 1587–1589.
   PubMed Web of Science ®Google Scholar
• Issacs JH. Cancer of the breast in pregnancy. Surg Clin North Am 1995; 75: 47–51.
   Google Scholar
• Jadeski LC, Lala PK. Nitric oxide synthase inhibition by NG-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors. Am J Pathol 1999; 155: 1381–1390.
   PubMedGoogle Scholar
• Jaggers DC, Collin WP, Milligan SR. Potent inhibitory effects of steroids in an in vitro model of angiogenesis. J Endocrinol 1996; 150: 457–464.
   Google Scholar
• Labarca C, Paigen, K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980; 102: 344–352.
   Google Scholar
• Lin AL, Gonzalez R Jr, Carey KD, ShaM SA. Estradiol-17$ affects estrogen receptor distribution and elevates progesterone receptor content in baboon aorta. Arterio-sclerosis 1986; 6: 495–504.
   PubMedGoogle Scholar
• Lonning PE, Lien EA, Lundgren S, Kvinnsland S. Clinical pharmacokinetics of endocrine agents used in advanced breast cancer. Clin Pharmacokinet 1992; 22: 327–358.
   PubMed Web of Science ®Google Scholar
• Marietta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988; 27: 8706–8711.
   Google Scholar
• Palmer RMJ, Ashton DS, Moncada S. Vascular endo-thelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664–666.
   Google Scholar
• Radomski MW, Jenkins DC, Holmes L, Moncada S. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggre-gate platelets. Cancer Res 1991; 51: 6073–6078.
   PubMed Web of Science ®Google Scholar
• Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17$-estradiol and norethisterone acetate. A two-year follow-up study. Hypertension 1995; 25: 848–853.
   Google Scholar
• Shultz PJ, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induce d glomerular thrombosis. J Clin Invest 1992; 90: 1718–1725.
   PubMed Web of Science ®Google Scholar
• Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res 1994; 54: 1352–1354.
   Google Scholar
• Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995; 72: 41–44.
   PubMed Web of Science ®Google Scholar
• Van Buren GA, Yang DS, Clark KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 1992; 167: 828–833.
   Google Scholar
• Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994; 91: 5212–5216.
   PubMed Web of Science ®Google Scholar
• Zeillinger R, Tantscher E, Schneeberger C, et al. Simul-taneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines. Breast Cancer Res Treat 1996; 40: 205–207.
   PubMed Web of Science ®Google Scholar